I've read elsewhere that Biotech companies typically burn through a lot of cash during the development phase of a new product. I am interested to hear people's opinion regarding BTA and the decision to give back 20 million in dividends to shareholders. Okay, so Relenza royalties will hopefully continue to cover expenses for a while to come, but I'm wondering if my 11cps dividend could be better spent in other areas such as product development or possible takeovers.
- Forums
- ASX - Short Term Trading
- BTA
- next flag
next flag, page-31
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)